Enzo Biochem Statistics

Total Valuation

Enzo Biochem has a market cap or net worth of EUR 30.49 million. The enterprise value is 1.85 million.

Market Cap	30.49M
Enterprise Value	1.85M

Important Dates

The next estimated earnings date is Monday, October 13, 2025.

Earnings Date	Oct 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	52.33M
Shares Outstanding	n/a
Shares Change (YoY)	+3.46%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	20.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.26
PB Ratio	0.80
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.10
EV / Sales	0.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.13

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.07.

Current Ratio	2.84
Quick Ratio	2.41
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-57.26

Financial Efficiency

Return on equity (ROE) is -13.95% and return on invested capital (ROIC) is -11.49%.

Return on Equity (ROE)	-13.95%
Return on Assets (ROA)	-8.98%
Return on Invested Capital (ROIC)	-11.49%
Return on Capital Employed (ROCE)	-24.26%
Revenue Per Employee	184,852
Profits Per Employee	-141,845
Employee Count	136
Asset Turnover	0.35
Inventory Turnover	2.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-43.00%
50-Day Moving Average	0.38
200-Day Moving Average	0.64
Relative Strength Index (RSI)	55.23
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.50

Income Statement

In the last 12 months, Enzo Biochem had revenue of EUR 24.22 million and -18.58 million in losses. Loss per share was -0.36.

Revenue	24.22M
Gross Profit	10.37M
Operating Income	-9.94M
Pretax Income	-6.91M
Net Income	-18.58M
EBITDA	-8.75M
EBIT	-9.94M
Loss Per Share	-0.36

Full Income Statement

Balance Sheet

The company has 32.34 million in cash and 2.65 million in debt, giving a net cash position of 29.69 million.

Cash & Cash Equivalents	32.34M
Total Debt	2.65M
Net Cash	29.69M
Net Cash Per Share	n/a
Equity (Book Value)	38.25M
Book Value Per Share	0.73
Working Capital	27.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.50 million and capital expenditures -905,198, giving a free cash flow of -14.41 million.

Operating Cash Flow	-13.50M
Capital Expenditures	-905,198
Free Cash Flow	-14.41M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 42.83%, with operating and profit margins of -41.06% and -76.73%.

Gross Margin	42.83%
Operating Margin	-41.06%
Pretax Margin	-28.54%
Profit Margin	-76.73%
EBITDA Margin	-36.13%
EBIT Margin	-41.06%
FCF Margin	n/a

Dividends & Yields

Enzo Biochem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.46%
Shareholder Yield	n/a
Earnings Yield	-60.94%
FCF Yield	-47.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Enzo Biochem has an Altman Z-Score of -4.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.84
Piotroski F-Score	2